Chief executive officer of Complementary Medicines Australia (CMA), Mr Carl Gibson, today welcomed the news that well-known industry member, Blackmores, has made a strategic investment in Australian manufacturing in a full acquisition of the world-class Catalent Australia tablet and soft-gel capsule manufacturing facility in Braeside, Victoria.

Read the release here